AARDEX GROUP SA
Grant-FundedCORDISDefining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis
Deep Tech
AARDEX GROUP SA is a private SME recorded in CORDIS in Switzerland, with participation in 4 EU research and innovation projects. Its recorded projects include “Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€804,469
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇨🇭Switzerland
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
AARDEX GROUP SA is a private SME recorded in CORDIS in Switzerland, with participation in 4 EU research and innovation projects. Its recorded projects include “Defining Clinical and Molecular Phenotypes of Multi-Drug Resistance in difficult to treat Rheumatoid Arthritis”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Deep Tech
Tags:Deep Tech
Company Info
AARDEX GROUP SA Info
Funding
EU Grants€804,469